BROWN BROTHERS HARRIMAN & CO
Position in REGN — Regeneron Pharmaceuticals, Inc.
CIK 14661
NEW YORK, NY
Position in REGN
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$695,247
-$697,050 QoQ
Shares Held
1,115
-38.1% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#729
of 1,329 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in REGN Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026BROWN BROTHERS HARRIMAN & CO holds $12,921,641 across 41 Biotechnology names. REGN ranks #5 (5.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
8,785 | $4,363,773 | |
| 2 | RVMD |
Revolution Medicines, Inc.
|
15,000 | $2,809,200 | |
| 3 | PCVX |
Vaxcyte, Inc.
|
38,033 | $2,210,858 | |
| 4 | INCY |
Incyte Corp
|
8,005 | $907,446 | |
| 5 | REGN |
Regeneron Pharmaceuticals, Inc.
This page
|
1,115 | $695,247 | |
| 6 | MRNA |
Moderna, Inc.
|
8,626 | $604,078 | |
| 7 | TECH |
BIO-TECHNE Corp
|
4,971 | $351,201 | |
| 8 | TTRX |
Turn Therapeutics Inc.
|
23,688 | $172,922 |
All Filings in REGN
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $695,247 | 1,115 | Shares | Sole | 2026-08-12 | |
| 2026-03-31 | $1,392,297 | 1,802 | Shares | Sole | 2026-05-14 | |
| 2025-12-31 | $822,041 | 1,065 | Shares | Sole | 2026-02-12 | |
| 2025-09-30 | $285,633 | 508 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $130,200 | 248 | Shares | Sole | 2025-08-11 | |
| 2025-03-31 | $176,315 | 278 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $375,397 | 527 | Shares | Sole | 2025-02-12 | |
| 2024-09-30 | $506,697 | 482 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $508,698 | 484 | Shares | Sole | 2024-08-09 | |
| 2024-03-31 | $483,169 | 502 | Shares | Sole | 2024-05-10 | |
| 2023-12-31 | $606,898 | 691 | Shares | Sole | 2024-02-12 | |
| 2023-09-30 | $531,632 | 646 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $247,177 | 344 | Shares | Sole | 2023-08-07 | |
| 2023-03-31 | $485,606 | 591 | Shares | Sole | 2023-05-11 | |
| 2022-12-31 | $410,527 | 569 | Shares | Sole | 2023-02-09 | |
| 2022-09-30 | $251,437 | 365 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $215,171 | 364 | Shares | Sole | 2022-08-11 | |
| 2022-03-31 | $264,002 | 378 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $209,033 | 331 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $344,952 | 570 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $315,016 | 564 | Shares | Sole | 2021-08-13 | |
| 2021-03-31 | $326,939 | 691 | Shares | Sole | 2021-05-13 | |
| 2020-12-31 | $829,016 | 1,716 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $921,957 | 1,647 | Shares | Sole | 2020-11-16 | |
| 2020-06-30 | $1,105,107 | 1,772 | Shares | Sole | 2020-08-13 | |
| 2020-03-31 | $220,218 | 451 | Shares | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||